A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Monyan Pharmaceutical (Shanghai) Co., Ltd.
Monyan Pharmaceutical (Shanghai) Co., Ltd.
Mersin University
Universidad de Granada
Bucheon St. Mary's Hospital
Nanfang Hospital, Southern Medical University
Ottawa Hospital Research Institute
Yonsei University
Federal University of Rio Grande do Sul
Hospital Universitari Vall d'Hebron Research Institute
Affiliated Hospital of Qinghai University
Saglik Bilimleri Universitesi
Federal University of Minas Gerais
M.D. Anderson Cancer Center
McGill University
Hospital General de Mexico
Hospital Aleman
The University of Hong Kong
National Taiwan University Hospital
Maltepe University
Yonsei University
Shanghai Zhongshan Hospital
Universidade Federal do Triangulo Mineiro
Guiyang Medical University
Universidade do Vale do ParaÃba
Shanghai Chest Hospital
University of Roma La Sapienza
Chang Bing Show Chwan Memorial Hospital
Simcere Pharmaceutical Co., Ltd
The Netherlands Cancer Institute